Title : [JSH guidelines for the management of hepatitis C virus infection (version 3)].

Pub. Date : 2015 Feb

PMID : 25764674






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In September 2014, the first IFN-free DAAs, daclatasvir (DCV) and asunaprevir (ASV), were launched and the antiviral therapy for IFN intolerant/ineligible patients became to be possible. daclatasvir interferon alpha 1 Homo sapiens
2 In September 2014, the first IFN-free DAAs, daclatasvir (DCV) and asunaprevir (ASV), were launched and the antiviral therapy for IFN intolerant/ineligible patients became to be possible. daclatasvir interferon alpha 1 Homo sapiens
3 In September 2014, the first IFN-free DAAs, daclatasvir (DCV) and asunaprevir (ASV), were launched and the antiviral therapy for IFN intolerant/ineligible patients became to be possible. daclatasvir interferon alpha 1 Homo sapiens